Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTY

		Cancer Friends Network > Types of Cancer > Non-Hodgkin Lymphoma
Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTY

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-31-2012, 03:26 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Allos Therapeutics Announces Interim Results from Phase 1 Combination Study of FOLOTY

Allos Therapeutics, Inc. today reported interim results from the Company’s ongoing Phase 1 combination study of FOLOTYN® and bexarotene in patients with relapsed or refractory cutaneous T-cell lymphoma .

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 05:43 AM.

CancerFriends.net